These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 1967895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of Parkinson's disease. From theory to practice.
    Ahlskog JE.
    Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of early Parkinson's disease: are complicated strategies justified?
    Ahlskog JE.
    Mayo Clin Proc; 1996 Jul; 71(7):659-70. PubMed ID: 8656708
    [Abstract] [Full Text] [Related]

  • 7. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK.
    Arch Neurobiol (Madr); 1991 Jul; 54(6):282-7. PubMed ID: 1687430
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An integrated approach to patient management in Parkinson's disease.
    Lieberman A.
    Neurol Clin; 1992 May; 10(2):553-65. PubMed ID: 1350053
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

  • 12. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
    Olanow CW, Hauser RA, Gauger L, Malapira T, Koller W, Hubble J, Bushenbark K, Lilienfeld D, Esterlitz J.
    Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
    [Abstract] [Full Text] [Related]

  • 13. Medical treatment of Parkinson's disease.
    Ahlskog JE.
    Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Parkinson's disease.
    Eadie MJ.
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T, Yahr MD.
    Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
    [Abstract] [Full Text] [Related]

  • 16. Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
    Chase TN, Baronti F, Fabbrini G, Heuser IJ, Juncos JL, Mouradian MM.
    Neurology; 1989 Nov; 39(11 Suppl 2):7-10; discussion 19. PubMed ID: 2685653
    [Abstract] [Full Text] [Related]

  • 17. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Bonnet AM, Serre I, Marconi R, Agid Y, Dubois B.
    Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
    Stocchi F, Marconi S.
    Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
    [Abstract] [Full Text] [Related]

  • 19. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 20. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.